Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

BACKGROUND: E2303 evaluated cetuximab, paclitaxel, and carboplatin used as induction therapy and concomitant with radiation therapy in patients with stage III/IV head and neck squamous cell carcinoma (HNSCC) determining pathologic complete response (CR), event-free survival (EFS), and toxicity. PATI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wanebo, H. J., Lee, J., Burtness, B. A., Ridge, J. A., Ghebremichael, M., Spencer, S. A., Psyrri, D., Pectasides, E., Rimm, D., Rosen, F. R., Hancock, M. R., Tolba, K. A., Forastiere, A. A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2014
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176450/
https://ncbi.nlm.nih.gov/pubmed/25009013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdu248
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge